Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Hengrui Pharmaceuticals Co., Ltd. Jiangsu currently holds 7,420,091 shares of Braveheart Bio, Inc. (BRVE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hengrui Pharmaceuticals Co., Ltd. Jiangsu has been a net neutral trader of BRVE stock. They have purchased $0 and sold $0 worth of shares.
Hengrui Pharmaceuticals Co., Ltd. Jiangsu's most recent insider trade was on Aug 7, 2026, when they sold 32,500,000 shares at $0.00 per share.
Hengrui Pharmaceuticals Co., Ltd. Jiangsu serves as Executive at Braveheart Bio, Inc. (BRVE). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Hengrui Pharmaceuticals Co., Ltd. Jiangsu holds the position of Executive at Braveheart Bio, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Hengrui Pharmaceuticals Co., Ltd. Jiangsu has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Hengrui Pharmaceuticals Co., Ltd. Jiangsu was on Aug 7, 2026, when they sold $0 worth of BRVE shares. This transaction involved 32,500,000 shares at N/A per share.
Hengrui Pharmaceuticals Co., Ltd. Jiangsu currently owns 7,420,091 shares of Braveheart Bio, Inc. (BRVE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Hengrui Pharmaceuticals Co., Ltd. Jiangsu's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Hengrui Pharmaceuticals Co., Ltd. Jiangsu has 2 Form 4 filings on record as an insider at Braveheart Bio, Inc..
Set alerts for Hengrui Pharmaceuticals Co., Ltd. Jiangsu and 40,000+ other insiders.